Dr. Adele Lafrance is a clinical psychologist, research scientist, author and co-developer of emotion-focused treatment modalities, including Emotion-Focused Ketamine-Assisted Psychotherapy. She is a leader in the research and practice of psychedelic medicine, with a focus on ayahuasca, MDMA, psilocybin and ketamine. Currently, Adele is the clinical investigator and strategy lead for a MAPS-sponsored study of MDMA-assisted psychotherapy. She is also a clinical trainer and supervisor for Imperial College Center for Psychedelic Research. Dr. Lafrance has a particular interest in mechanisms and models of healing, including emotion processing, spirituality and family-based psychedelic medicine.
